ロード中...
Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
OBJECTIVE: Immune complexes (ICs) play a critical role in the pathology of autoimmune diseases. The aim of this study was to generate and characterise a first-in-class anti-FcγRIIA antibody (Ab) VIB9600 (previously known as MEDI9600) that blocks IgG immune complex-mediated cellular activation for cl...
保存先:
| 出版年: | Ann Rheum Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6352406/ https://ncbi.nlm.nih.gov/pubmed/30459279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2018-213523 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|